drugset
drugset / Trial / NCT01599962

Influence of Cincalcet on Cognitive Functions in Healthy Human Subjects

NCT01599962 ↗

Phase 2 Completed 40 enrolled University of Basel Clinical Trial Unit, University Hospital Basel, Switzerland · collab
RandomizedCrossoverTriple-blindBasic science

Summary

To investigate the effects of the calcimimetic agent cinacalcet on cognitive functions in healthy humans.

Timeline

Start
2012-03
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Cinacalcet Other / unclassified 90 mg —

Indications

No indication recorded.